SU
Sandeep Umeshchandra Arora
About Sandeep Umeshchandra Arora
Sandeep Umeshchandra Arora has 14 years in corporate governance. Holds Director role. Currently with 3 companies, including Chieron Active Ingredients Private Limited and Glochem Industries Private Limited. Formerly with 3 companies, such as I-Design Engineering Solutions Limited and Piramal Glass Private Limited. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Chieron Active Ingredients Private Limited
U21001TS2024PTC189157
|
Director | 29 Jan 2025 | 2024 | Active |
Glochem Industries Private Limited
U24230TG2020PTC146205
|
Director | 15 May 2025 | 2020 | Active |
|
Audhataam Pharmaceuticals Private Limited
U70200TS2024PTC189303
|
Director | 29 Jan 2025 | 2024 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
I-Design Engineering Solutions Limited
U29999PN1998PLC012660
|
Director | 01 Feb 2018 | 1998 | Active |
Piramal Glass Private Limited
U28992MH1998PTC113433
|
Manager | 01 Jan 2012 | 1998 | Active |
Drg Analytics & Insights Private Limited
U74900KA2015FTC080238
|
Director | 11 May 2015 | 2015 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Frequently Asked Questions about Sandeep Umeshchandra Arora
Sandeep Umeshchandra Arora has 14 years in corporate governance. Holds Director role. Currently with 3 companies, including Chieron Active Ingredients Private Limited and Glochem Industries Private Limited. Formerly with 3 companies, such as I-Design Engineering Solutions Limited and Piramal Glass Private Limited. Engaged in General Business. Contributes to corporate operations.
Sandeep Umeshchandra Arora is associated with 3 companies as Director.
Sandeep Umeshchandra Arora has expertise in General Business.
Sandeep Umeshchandra Arora has 14 years in corporate governance.